Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 91 of the 95 references it cites were found in a registry or an index; 21 of the 71 sources its claims cite were checked for support.

Respiratory Responses to Two Voice Interventions for Parkinson's Disease

Open access
Richardson, Kelly, Huber, Jessica E., Kiefer, Brianna, Kane, Caitlin, Snyder, Sandy · 2022 · Journal of Speech, Language, and Hearing Research

Abstract

PURPOSE: The purpose of this study was to examine the respiratory strategies used by persons with Parkinson's disease (PD) to support louder speech in response to two voice interventions. Contrasting interventions were selected to investigate the role of internal and external cue strategies on treatment outcomes. LSVT LOUD, which uses an internal cueing framework, and the SpeechVive prosthesis, which employs an external noise cue to elicit louder speech, were studied. METHOD: = 10). The LSVT LOUD and SpeechVive participants received 8 weeks of voice intervention. Acoustic and respiratory kinematic data were simultaneously collected at pre-, mid- and posttreatment during a monologue speech sample. Intervention outcomes included sound pressure level (SPL), utterance length, lung volume initiation, lung volume termination, and lung volume excursion. RESULTS: As compared to controls, the LSVT LOUD and SpeechVive participants significantly increased SPL at mid- and posttreatment, thus confirming a positive intervention effect. Treatment-related changes in speech breathing were further identified, including significantly longer utterance lengths (syllables per breath group) at mid- and posttreatment, as compared to pretreatment. The respiratory strategies used to support louder speech varied by group. The LSVT LOUD participants terminated lung volume at significantly lower levels at mid- and posttreatment, as compared to pretreatment. This finding suggests the use of greater expiratory muscle effort by the LSVT LOUD participants to support louder speech. Participants in the SpeechVive group did not significantly alter their respiratory strategies across the intervention period. Single-subject effect sizes highlight the variability in respiratory strategies used across speakers to support louder speech. CONCLUSIONS: This study provides emerging evidence to suggest that the LSVT LOUD and SpeechVive therapies elicit different respiratory adjustments in persons with PD. The study highlights the need to consider respiratory function when addressing voice targets in persons with PD.

Overview

CoChat Summary

## TL;DR

This multisite study compared LSVT LOUD and SpeechVive in 34 people with hypophonia secondary to idiopathic Parkinson’s disease to see whether internal versus external cueing led to different respiratory strategies for louder speech. Both interventions increased sound pressure level, but the respiratory changes differed by treatment: LSVT LOUD was associated with lower lung volume termination, while SpeechVive showed little group-level change in respiratory strategy.

## Key findings

  • Sample and intervention effects: 34 participants were assigned to LSVT LOUD (n = 12), SpeechVive (n = 12), or clinical control (n = 10); the two treatment groups received 8 weeks of intervention.
  • Sound pressure level (SPL): The LSVT LOUD and SpeechVive groups significantly increased SPL, while the clinical controls did not. For SPL, the paper reports a significant group effect (p = .022), session effect (p < .0001), and group × session interaction (p < .0001).
  • Utterance length: Utterance length increased by 1.48 syllables per breath group at midtreatment and 1.05 syllables per breath group at posttreatment versus pretreatment; the authors say these increases were statistically significant but not clinically meaningful.
  • Respiratory strategy differed by intervention:
  • LSVT LOUD participants terminated lung volume at significantly lower levels at midtreatment and posttreatment than pretreatment, suggesting greater expiratory muscle effort.
  • SpeechVive participants did not significantly alter respiratory strategies at the group level.
  • Single-subject variability was substantial: The paper reports that 17 speakers showed a significant effect size for lung volume initiation, 16 speakers for lung volume termination, and 9 speakers for lung volume excursion for one or more session comparisons, underscoring variability across individuals.

## Methods

  • Design: Multisite intervention study with three groups (LSVT LOUD, SpeechVive, clinical control); acoustic and respiratory kinematic data were collected at pre-, mid-, and posttreatment during monologue speech samples.
  • Sample: 34 people with hypophonia secondary to idiopathic PD; 12 in LSVT LOUD, 12 in SpeechVive, 10 clinical controls. The text also states 11 participants had mild cognitive impairment and 23 had normal cognition.
  • Analysis: The authors used linear mixed-model ANOVAs: a 3 × 3 model for SPL and a 2 × 2 × 3 model for utterance length and lung volume measures, with Tukey HSD post hoc tests and single-subject effect sizes; intermeasurer reliability was assessed on 10% of the data with mean ICC = .969.

## Limitations

  • Stated by the paper: The sample was relatively small (12 per intervention group), so the authors caution against generalizing to a larger clinical population.
  • Stated by the paper: Group matching by auditory-perceptual hypophonia severity left baseline vocal intensity differences between controls and the LSVT LOUD group; the authors suggest future studies use a quantitative metric or consensus ratings.
  • Stated by the paper: Because PD is heterogeneous and prior work shows variability, the authors say an extended baseline period should be considered in future studies.
  • Stated by the paper: They could not report abdominal volume contributions because participants were unable to complete the abdominal calibration maneuvers reliably.
  • Evident from the text: Posttreatment data were not collected for five participants because of the SARS-CoV-2 pandemic, and one LSVT LOUD participant dropped out after midtreatment, which reduces complete longitudinal coverage.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1044/2022_jslhr-22-00262

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

18 Valid · 4 Not valid · 18 Not checked · 135 Own results and interpretations

104 more claims · 8 with their cited sources checked

Create a free account to see all 175 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 46
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Not confirmedt(31) = 2.78reported p = .024 · recomputed p = .009

    “t(31) = 2.78, p = .024”

  • Not confirmedt(56) = 1.77reported p = .7 · recomputed p = .082

    “t(56) = 1.77, p = .700”

  • Not confirmedt(56) = 1.99reported p = .557 · recomputed p = .051

    “t(56) = 1.99, p = .557”

  • Not confirmedt(56) = 0.94reported p = .989 · recomputed p = .351

    “t(56) = 0.94, p = .989”

  • Not confirmedt(56) = 0.97reported p = .987 · recomputed p = .336

    “t(56) = 0.97, p = .987”

5 of 25 · the rest aren’t loaded

20 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Citations

Cites

Show all 95 references

Research works printed but not linked: 2

  1. Huber, J. E. , Stathopoulos, E. T. , Ramig, L. O. , & Lancaster, S. L. (2003). Respiratory function and variability in individuals with Parkinson disease: Pre– and post–Lee Silverman Voice Treatment. Journal of Medical Speech-Language Pathology, 11(4), 185–201.
  2. Lombard, E. (1911). Le signe de l'élévation de la voix. Annales des Maladies de L'Oreille et du Larynx, 37, 101–119.

Cited by

See all 7

Metadata

Authors
Richardson, K., Huber, J. E., Kiefer, B., Kane, C., & Snyder, S.
Affiliations
  • University of Massachusetts Amherst (US)
  • Purdue University West Lafayette (US)
Venue
Journal of Speech, Language, and Hearing Research
Published
2022-10-17
Volume
65
Issue
10
Pages
3730-3748
ISSN
  • 1092-4388 (ISSN-L)
  • 1558-9102
OpenAlex
W4297347213
Cited by
7
References
95
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2
FWCI
0.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Speech Language and Hearing Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Deafness and Other Communication Disorders (R21DC016718)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Phonetics and Phonology Research
  • Health Sciences › Health Professions › Occupational Therapy › Assistive Technology in Communication and Mobility
Keywords
Parkinson's disease, voice therapy, LSVT LOUD, speech prosthesis, loudness, lung volume, sound pressure level, utterance length, speech breathing
MeSH terms
Humans, Parkinson Disease, Speech, Speech Disorders, Voice Disorders, Voice Training

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Respiratory Responses to Two Voice Interventions for Parkinson's Disease. https://app.cochat.ai/papers/10.1044/2022_jslhr-22-00262
The paper
Richardson, K., Huber, J. E., Kiefer, B., Kane, C., & Snyder, S. (2022). Respiratory Responses to Two Voice Interventions for Parkinson's Disease. Journal of Speech, Language, and Hearing Research. https://doi.org/10.1044/2022_jslhr-22-00262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.